| Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments EJS Sonuga-Barke, D Brandeis, S Cortese, D Daley, M Ferrin, ... American journal of psychiatry 170 (3), 275-289, 2013 | 1566 | 2013 |
| Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta … S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen, AJ Hayes, ... The Lancet Psychiatry 5 (9), 727-738, 2018 | 1210 | 2018 |
| European clinical guidelines for hyperkinetic disorder–first upgrade E Taylor, M Döpfner, J Sergeant, P Asherson, T Banaschewski, ... European child & adolescent psychiatry 13, i7-i30, 2004 | 1156 | 2004 |
| The quality of life of children with attention deficit/hyperactivity disorder: a systematic review M Danckaerts, EJS Sonuga-Barke, T Banaschewski, J Buitelaar, ... European child & adolescent psychiatry 19, 83-105, 2010 | 715 | 2010 |
| Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials S Cortese, M Ferrin, D Brandeis, J Buitelaar, D Daley, RW Dittmann, ... Journal of the American Academy of Child & Adolescent Psychiatry 54 (3), 164-174, 2015 | 663 | 2015 |
| Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline T Banaschewski, D Coghill, P Santosh, A Zuddas, P Asherson, J Buitelaar, ... European child & adolescent psychiatry 15, 476-495, 2006 | 588 | 2006 |
| European guidelines on managing adverse effects of medication for ADHD J Graham, T Banaschewski, J Buitelaar, D Coghill, M Danckaerts, ... European child & adolescent psychiatry 20, 17-37, 2011 | 529 | 2011 |
| Psychosocial risk factors for suicidality in children and adolescents JJ Carballo, C Llorente, L Kehrmann, I Flamarique, A Zuddas, ... European child & adolescent psychiatry 29, 759-776, 2020 | 393 | 2020 |
| Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials S Cortese, M Ferrin, D Brandeis, M Holtmann, P Aggensteiner, D Daley, ... Journal of the American Academy of Child & Adolescent Psychiatry 55 (6), 444-455, 2016 | 383 | 2016 |
| ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group S Cortese, P Asherson, E Sonuga-Barke, T Banaschewski, D Brandeis, ... The Lancet Child & Adolescent Health 4 (6), 412-414, 2020 | 287 | 2020 |
| Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns B Vitiello, C Correll, B van Zwieten-Boot, A Zuddas, M Parellada, ... European Neuropsychopharmacology 19 (9), 629-635, 2009 | 261 | 2009 |
| Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate … L Hennissen, MJ Bakker, T Banaschewski, S Carucci, D Coghill, ... CNS drugs 31, 199-215, 2017 | 249 | 2017 |
| Contrasting deficits on executive functions between ADHD and reading disabled children GM Marzocchi, J Oosterlaan, A Zuddas, P Cavolina, H Geurts, D Redigolo, ... Journal of Child Psychology and Psychiatry 49 (5), 543-552, 2008 | 243 | 2008 |
| Prevalence and correlates of mental disorders among adolescents in Italy: the PrISMA study A Frigerio, P Rucci, R Goodman, M Ammaniti, O Carlet, P Cavolina, ... European child & adolescent psychiatry 18, 217-226, 2009 | 221 | 2009 |
| Practitioner review: current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit … D Daley, S Van Der Oord, M Ferrin, S Cortese, M Danckaerts, M Doepfner, ... Journal of Child Psychology and Psychiatry 59 (9), 932-947, 2018 | 211 | 2018 |
| Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study D Michelson, JK Buitelaar, M Danckaerts, C Gillberg, TJ Spencer, ... Journal of the American Academy of Child & Adolescent Psychiatry 43 (7), 896-904, 2004 | 198 | 2004 |
| MK‐801 prevents 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐induced parkinsonism in primates A Zuddas, G Oberto, F Vaglini, F Fascetti, F Fornai, GU Corsini Journal of neurochemistry 59 (2), 733-739, 1992 | 186 | 1992 |
| Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis T Usala, A Clavenna, A Zuddas, M Bonati European neuropsychopharmacology 18 (1), 62-73, 2008 | 167 | 2008 |
| The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles RD Oades, AG Sadile, T Sagvolden, D Viggiano, A Zuddas, P Devoto, ... Developmental Science 8 (2), 122-131, 2005 | 167 | 2005 |
| Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies A Zuddas, R Zanni, T Usala European Neuropsychopharmacology 21 (8), 600-620, 2011 | 148 | 2011 |
